Bradykinesia, muscle weakness and reduced muscle power in Parkinson's disease.
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.1002/mds.22609
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Allen NE, Canning CG, Sherrington C, Fung VS. Bradykinesia, muscle weakness and reduced muscle power in Parkinson's disease. Mov Disord. 2009;24(9):1344–51. DOI 10.1002/mds.22609
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — strength
- access status: primary_abstract_or_excerpt_only
STR-30-01
Limitations: Only current scoped checks; archived captures not authenticated against live originals.
Parkinson’s disease strength
- current access: primary_abstract_or_excerpt_only
- primary version: Primary abstract or excerpt
Parkinson’s disease strength component — Allen case-control strength, power and load-dependent velocity
The abstract matches 40 PD/40 controls, 172 N lower strength and 124 W lower peak power with quoted CIs, and velocity deficits at light/medium rather than heavy loads.
Source locator: Primary abstract
Limitations: AI-assisted source comparison; no raw-data verification.
Reports citing this source
- Strength muscle power and rapid force production assessment in Parkinson’s disease · reference 30 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide